openPR Logo
Press release

Anti-aging Therapeutics Market

12-09-2024 11:58 AM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd

Anti-aging Therapeutics Market

Anti-aging Therapeutics Market

Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Anti-aging Therapeutics Market- by Type of Molecules (Biologics and Small Molecules), Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging and Others), Mechanism of Action (Senolytic, Cell Regeneration, mTOR inhibitor/Modulator, AMP-kinase/AMP Activator, Mitochondria Inhibitor/Modulator and Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

Get Free Access to Demo Report, Excel Pivot and ToC :https://www.insightaceanalytic.com/request-sample/1249

According to the latest research by Insight Analytics, the global Anti-aging Therapeutics market was valued at US$ 518.86 Million in 2021. It is expected to reach US$ 2013.51 Million by 2030, with a CAGR of 16.53 % during a forecast period of 2022-2030.

Age-related ailments are becoming more common as populations age, raising individual and societal issues. Elderly patients have a greater need than ever for effective regenerative medicine treatments. A brand-new area of medical research called anti-aging therapeutics has arisen. Identifying, treating, and reversing age-related dysfunctions, illnesses, and diseases is the goal of anti-aging diagnosis and therapy, a subset of medicine and healthcare. Before conducting human trials, several cells, insect, and animal models may serve as valuable starting points for developing anti-aging medications.
Companies developing anti-aging pharmaceuticals with a successful launch of longevity therapies have significant promise. Despite these positive advancements in the study of aging, several obstacles will become apparent after an anti-aging drug goes through a problematic clinical trial process. The rising desire for personalized, precise, preventative, and participatory aging therapies are the two main factors driving the market. Therefore, the demand for anti-aging treatments increases as the older population grows. The market is being driven forward by advanced technological development and R&D spending on anti-aging products. Companies in the industry have mainly created ground-breaking anti-aging treatment items to fulfil the rising demand for technologically improved solutions among clients.
North America is anticipated to contribute to the Anti-aging Therapeutics market over the years. Due to increased investment in pharmaceutical design, manufacture, and senescent cell research, pharmaceutical research and development is increasing in developed economies like the United States and Canada. In addition, the Asia Pacific Anti-aging Therapeutics market is expected to grow significantly during the forecast period. The country's steadily rising older population is a prospective consumer base for anti-aging treatments, fueling regional growth.

Expert Knowledge, Just a Click Away:https://calendly.com/insightaceanalytic/30min?month=2024-02

Major market players operating in the Anti-aging Therapeutics market include AgelessRx, ANOVA Institute for Regenerative Medicine, Betterhumans, BioAge Labs, BIOPHYTIS BSA, bioXcellerator, Cambrian Biopharma, CytoMed Therapeutics, Gero.ai, Rejuvenate Bio, Rejenevie Therapeutics, UT Health San Antonio, MyMD Pharmaceuticals, Intervene Immune, Inc., CohBar, Inc., Alkahest, Athersys Inc, BHB Therapeutics, Biosplice, Cyclo Therapeutics, Denali Therapeutics, Elysium Health, Genome Protection, GenSight Biologics, Intervene Immune, Khondrian, Longeveron, LyGenesis, Mesoblast, Minovia Therapeutics, Mitobridge, Navitor Pharmaceuticals, NeuroTrack, Nuchido, NuSirt, OneSkin Technologies, PharmatrophiX, Proteostasis Therapeutics, Retrotope, Stealth Biotherapeutics, TA Sciences, Unity BiotechnologyYounger Phenotype, and Other Prominent Players.

Recent collaborations and agreements in the market:
• In February 2022, To promote novel, picky medications that target the mTOR pathway, Cambrian Biopharma stated that it had agreed to a license agreement with Novartis. Novartis was the one who came up with and defined these substances. The licensed assets are structural analogs of the rapamycin medication, according to a statement from Cambrian Biopharma. According to the data provided by Cambrian Biopharma, this medication has been demonstrated to extend mouse longevity by up to 31% and to prevent or reverse several age-related health impairments.
• In May 2019, RejenevieTM Therapeutics began a Phase II clinical trial to examine the security and efficacy of its novel AR-100 immune restoration therapy, which aims to improve the function of the immune system as it ages. The biotechnology company is in the clinical stages of development and has created the first stem cell therapies to treat age-related diseases.

Unlock Your GTM Strategy:https://www.insightaceanalytic.com/customisation/1249

Market Segments
Global Anti-aging Therapeutics Market, by Type of Molecules, 2022-2030 (Value US$ Mn)
• Biologics
• Small Molecules
Global Anti-aging Therapeutics Market, by Type of Aging, 2022-2030 (Value US$ Mn)
• Cellular Aging
• Immune Aging
• Metabolic Aging
• Others
Global Anti-aging Therapeutics Market, by Mechanism of Action, 2022-2030 (Value US$ Mn)
• Senolytic
• Cell Regeneration
• mTOR inhibitor/Modulator
• AMP-kinase/AMP Activator
• Mitochondria Inhibitor/Modulator
• Others
Global Anti-aging Therapeutics Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Anti-aging Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Anti-aging Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Anti-aging Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Anti-aging Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Anti-aging Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
o Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Anti-aging Therapeutics market
 To receive an industry overview and future trends in the Anti-aging Therapeutics market
 To analyze the Anti-aging Therapeutics market drivers and challenges
 To get information on the Anti-aging Therapeutics market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Anti-aging Therapeutics market industry

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/1249

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-aging Therapeutics Market here

News-ID: 3778683 • Views:

More Releases from InsightAce Analytic Pvt. Ltd

Protein Design and Engineering Market Demand and Growth Opportunities Detailed Analysis Report 2025-2034
Protein Design and Engineering Market Demand and Growth Opportunities Detailed A …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Protein Design and Engineering Market Market- by Type of Protein Engineering Approach (Rational Designing, Directed Evolution and Semi-Rational Designing), Protien Types (Antibodies, Peptides, Enzymes, Vaccines and Others), Type of Application (Therapeutics and Diagnostics), End-Users (Pharma/Biotech Firms, CROs and Research and Academic Institutes), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." According to the latest research
Pharmacy Automation Market Demand and Growth Opportunities Detailed Analysis Report 2025-2034
Pharmacy Automation Market Demand and Growth Opportunities Detailed Analysis Rep …
The Global Pharmacy Automation Market Size is valued at 6.7 Billion in 2024 and is predicted to reach 15.86 Billion by the year 2034 at an 9.1% CAGR during the forecast period for 2025-2034. Global Pharmacy Automation Market 2025-2034 full Research Repot latest version is now available. Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1483 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global pharmacy automation market are: •
Pharmaceutical Contract Sales Outsourcing [CSO] Market Demand and Growth Opportunities Detailed Analysis Report 2025-2034
Pharmaceutical Contract Sales Outsourcing [CSO] Market Demand and Growth Opportu …
Pharmaceutical Contract Sales Outsourcing [CSO] Market Size is valued at USD 10.80 Bn in 2024 and is predicted to reach USD 25.80 Bn by the year 2034 at a 9.2% CAGR during the forecast period for 2025-2034. Global Pharmaceutical Contract Sales Outsourcing Market 2025-2034 full Research Repot latest version is now available. Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2063 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the
Multi Cancer Early Detection Market Demand and Growth Opportunities Detailed Analysis Report 2025-2034
Multi Cancer Early Detection Market Demand and Growth Opportunities Detailed Ana …
The Multi Cancer Early Detection Market Size is valued at 1.20 Billion in 2024 and is predicted to reach 5.60 Billion by the year 2034 at a 16.8% CAGR during the forecast period for 2025-2034. Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1408 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global multi-cancer early detection market are: • Increasing prevalence of cancer diseases • Increasing healthcare expenditure and growing

All 5 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growth
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin's
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways from
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant